TFIPS
ALXN

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Alexion Pharmaceuticals ALXN Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,155
Closed -$212K – 397
2021
Q2 		$212K Hold
1,155
– – 0.25% 52
2021
Q1 		$177K Hold
1,155
– – 0.26% 58
2020
Q4 		$180K Buy
+1,155
New +$148K 0.19% 55

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's ALXN Position: Q3 2021 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,155 shares — an estimated $212K sold.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $212K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA sold 1,155 Alexion Pharmaceuticals shares in Q3 2021, an estimated $212K.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Alexion Pharmaceuticals position peaked at $212K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q3 2021, filed 14 Aug 2025.